We are delighted to announce that from 1st July 2024, PHOENIX will enter a 2 Reduced Wholesale Model agreement for distribution of AstraZeneca’s portfolio of medicines in the UK.
Customers can purchase the following products through PHOENIX from 1st July:
- Arimidex
- Bevespi
- Bricanyl
- Brilique
- Bydureon BCise
- Byetta
- Casodex
- Crestor
- Daxas
- Faslodex
- Forxiga
- Komboglyze
- Lokelma
- Onglyza
- Oxis
- Pulmicort
- Qtern
- Symbicort
- Trixeo
- Xigduo
- Zoladex